Elisabeth Odin

604 total citations
39 papers, 531 citations indexed

About

Elisabeth Odin is a scholar working on Oncology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Elisabeth Odin has authored 39 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Rheumatology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Elisabeth Odin's work include Folate and B Vitamins Research (19 papers), Colorectal Cancer Treatments and Studies (18 papers) and Genetic factors in colorectal cancer (11 papers). Elisabeth Odin is often cited by papers focused on Folate and B Vitamins Research (19 papers), Colorectal Cancer Treatments and Studies (18 papers) and Genetic factors in colorectal cancer (11 papers). Elisabeth Odin collaborates with scholars based in Sweden, United States and Netherlands. Elisabeth Odin's co-authors include Yvonne Wettergren, Bengt Gustavsson, Göran Carlsson, Kristoffer Derwinger, Helena Taflin, Staffan Nilsson, Colin Paul Spears, Roger Wïllén, Lars Larsson and Peter V. Danenberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Elisabeth Odin

37 papers receiving 521 citations

Peers

Countries citing papers authored by Elisabeth Odin

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Odin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Odin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Odin more than expected).

Fields of papers citing papers by Elisabeth Odin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Odin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Odin. The network helps show where Elisabeth Odin may publish in the future.

Co-authorship network of co-authors of Elisabeth Odin

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Odin. A scholar is included among the top collaborators of Elisabeth Odin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Odin. Elisabeth Odin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased MLH1 , MGMT , and p16INK4a methylation levels in colon mucosa potentially useful as early risk marker of colon cancer 2025 ·Molecular & Cellular Oncology ·Yvonne Wettergren, P. Rolny, (unknown), Elisabeth Odin, Victoria Rotter Sopasakis, (unknown), Katarina Ejeskär	2
2	Increased potentiation of 5-fluorouracil induced thymidylate synthase inhibition by 5,10-methylenetetrahydrofolate (arfolitixorin) compared to leucovorin in patients with colorectal liver metastases; The Modelle-001 Trial 2024 ·SHILAP Revista de lepidopterología ·Helena Taflin, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Oskar Hemmingsson, Yvonne Wettergren, Krzysztof Urbanowicz, Jacek Turyn, Ryszard T. Smoleński, Godefridus J. Peters	4
3	Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer 2022 ·Cancers ·Helena Taflin, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren, Elinor Bexe Lindskog	2
4	Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin 2020 ·Cancer Chemotherapy and Pharmacology ·Helena Taflin, Elisabeth Odin, Göran Carlsson, Roger Tell, Bengt Gustavsson, Yvonne Wettergren	3
5	Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer 2018 ·Cancer Chemotherapy and Pharmacology ·Helena Taflin, Elisabeth Odin, Kristoffer Derwinger, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren	7
6	Expression of folate pathway genes with putative impact on leucovorin metabolism and outcome of patients with advanced colorectal cancer 2017 ·Annals of Oncology ·Elisabeth Odin, (unknown), (unknown), Anders Edsjö, Göran Carlsson, A Vedin, Bengt Gustavsson, Yvonne Wettergren	2
7	Reduced folate and serum vitamin metabolites in patients with rectal carcinoma 2016 ·Anti-Cancer Drugs ·C. Stoffregen, Elisabeth Odin, Göran Carlsson, Göran Kurlberg, (unknown), (unknown), Bengt Gustavsson	7
8	Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action 2016 ·Critical Reviews in Oncology/Hematology ·Peter V. Danenberg, Bengt Gustavsson, Patrick Johnston, Per Lindberg, Rudolf Moser, Elisabeth Odin, Godefridus J. Peters, Nicholas J. Petrelli	39
9	Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer 2015 ·Investigational New Drugs ·Bengt Gustavsson, Göran Carlsson, (unknown), Göran Kurlberg, Kristoffer Derwinger, (unknown), Elisabeth Odin, F A Gibson	2
10	A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study 2014 ·Cancer Chemotherapy and Pharmacology ·Yvonne Wettergren, Helena Taflin, Elisabeth Odin, Karl Kodeda, Kristoffer Derwinger	10
11	Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy 2014 ·Cancer Chemotherapy and Pharmacology ·Göran Carlsson, Elisabeth Odin, Bengt Gustavsson, Yvonne Wettergren	21
12	MTHFR, MTR, and MTRR Polymorphisms in Relation to p16INK4A Hypermethylation in Mucosa of Patients with Colorectal Cancer 2010 ·Molecular Medicine ·Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson	28
13	A Study of the MTHFR Gene Polymorphism C677T in Colorectal Cancer 2009 ·Clinical Colorectal Cancer ·Kristoffer Derwinger, Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson	38
14	Molecular determinants of efficacy for 5‐FU‐based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy‐related genes 2008 ·International Journal of Cancer ·Bengt Gustavsson, Christopher Kaiser, Göran Carlsson, Yvonne Wettergren, Elisabeth Odin, Elinor Bexe Lindskog, Clet Niyikiza, Doreen Ma	33
15	p16INK4a Gene Promoter Hypermethylation in Mucosa as a Prognostic Factor for Patients with Colorectal Cancer 2008 ·Molecular Medicine ·Yvonne Wettergren, Elisabeth Odin, Staffan Nilsson, Göran Carlsson, Bengt Gustavsson	31
16	Expression and Clinical Significance of Methylenetetrahydrofolate Reductase in Patients with Colorectal Cancer 2006 ·Clinical Colorectal Cancer ·Elisabeth Odin, Yvonne Wettergren, Göran Carlsson, Peter V. Danenberg, (unknown), Roger Wïllén, Bengt Gustavsson	15
17	Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients 2005 ·Cancer Detection and Prevention ·Yvonne Wettergren, Elisabeth Odin, Staffan Nilsson, Roger Wïllén, Göran Carlsson, Bengt Gustavsson	8
18	Rapid method for relative gene expression determination in human tissues using automated capillary gel electrophoresis and multicolor detection 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Elisabeth Odin, Yvonne Wettergren, Lars Larsson, Per-Anders Larsson, Bengt Gustavsson	5
19	Chemical Stability and Human Plasma Pharmacokinetics of Reduced Folates 1998 ·Cancer Investigation ·Elisabeth Odin, Göran Carlsson, Roland Frösing, Bengt Gustavsson, Colin Paul Spears, Per-Anders Larsson	13
20	Antitumour effects of pure diastereoisomers of 5-formyltetrahydrofolate in hepatic transplants of a rodent colon carcinoma model 1995 ·Biochemical Pharmacology ·Göran Carlsson, Bengt Gustavsson, Roland Frösing, Elisabeth Odin, Larsolof Hafström, Colin Paul Spears, Per-Anders Larsson	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact